Institute
of
Oncology
Research
Tools
Directory
www.usi.ch
Info Desk
IOR
An institute
affiliated to USI
The Institute
Research
Groups
Groups
Education
News and events
News and events
About
About
Staff
Staff
Foundation
Foundation
Facilities
Facilities
Open positions
Open positions
Support us
Support us
Partners & Supporters
Partners & Supporters
Contact
Contact
Bioinformatics Core Unit
Genomics Facility
Overview
Overview
Research Programs
Annual Reports
Annual Reports
Publications
Publications
Lymphoma and Genomics
Lymphoma and Genomics
Tumor Biology and Experimental Therapeutics
Tumor Biology and Experimental Therapeutics
Overview
Overview
Cancer Immunotherapy (Calcinotto)
Cancer Immunotherapy (Calcinotto)
Experimental Hematology (Rossi)
Experimental Hematology (Rossi)
Experimental Therapeutics (Catapano)
Experimental Therapeutics (Catapano)
Functional Cancer Genomics (Theurillat)
Functional Cancer Genomics (Theurillat)
Lymphoma Genomics (Bertoni)
Lymphoma Genomics (Bertoni)
Molecular Oncology (Alimonti)
Molecular Oncology (Alimonti)
Prostate Cancer Biology (Carbone)
Prostate Cancer Biology (Carbone)
Stem Cells and Cancer
Stem Cells and Cancer
Team
Publications
Partners
Contact
Characterization of the immune landscape of human breast and ovarian tumours
A co-clinical approach to study the immune evolution of breast cancer
The contribution of tumour-infiltrating myeloid cells in dictating tumour clonal evolution
The role of the gut and tissue-associated microbiota in shaping the tumour-infiltrating immune response
Contact
Partners
Publications
Research projects
Team
Adaptation of chronic lymphocytic leukemia to ibrutinib
Genetic and phenotypic attributes of splenic marginal zone lymphoma
Circulating tumor DNA uncovers the genetic and clinical heterogeneity of classic Hodgkin lymphoma
Team
Contact
Publications
Partners
Research projects
Epigenetic regulators and the potential of epigenetic therapies
Cancer stem cells and novel therapeutic approaches
Contact
Team
Publications
Research projects
Partners
Synthetic lethality between truncal mutations in SPOP and ERG in prostate cancer
Prostate cancer transcriptome analysis reveals common path towards disease progression
Antagonistic driver genes in prostate cancer in genomic models
Team
Partners
Publications
Contact
Research projects
Team
Research Areas - Senescence and Senolytics
Research Areas - Cell signaling and modelling
Research Areas - Clinical trials
Research Areas - Immuno-oncology
Research Areas - Microbiota
Research Areas - Cancer metabolism
Partners
Publications
Team
Research projects
Epigenetics and progression of ERG fusion-positive prostate cancers
Role of ESE3/EHF factor in prostate cancer
Extracellular vesicles as mediators and biomarkers in prostate cancer
Contact
Contact
Partners
Publications
Team
Education and training
Education and training
PhD Program
PhD Program
News
News
Events
Events
Events
04
May
2024
04.
May.
2024
XXVIII Dies academicus
News Cancer immunotherapy Group
All the years
2023
2022
2021
2020
2019
2018
2017
2016
Important discovery at the IOR
Pfizer Research Award, IRB and IOR researchers among winners
AliperTherapeutics, a spin-off of IOR, wins the fifth edition of Boldbrain Startup Challenge
Immuno-oncology, a winning alliance
Prestigious professorship awarded at the Institute of Oncology Research in Bellinzona
IOR study reveals how breast cancer therapy may be effective against COVID-19
Pfizer Prize 2020, awards for IRB and IOR researchers in oncology and neurology
Prostate cancer, accolades for two IOR researchers
IOR Bellinzona, new frontiers of research in biomedicine